Notice of AGM and Annual Report 2021

RNS Number : 8365G

Belluscura PLC

01 April 2022

 

Belluscura plc

("Belluscura" or the "Company" or "Group")

 Notice of AGM and Annual Report 2021

LONDON, U.K. AND PLANO, TX, U.S. (1 April 2022).   Belluscura plc (AIM:BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that the Notice of Annual General Meeting ("Notice") is being posted shareholders today and will shortly be available on the Company's website at: https://investors.belluscura.com/investors/shareholder-information.

The Annual Report and Accounts for the year ended 31 December 2021 is being posted along with the Notice and will be available on the Company's website at: https://investors.belluscura.com/investors/annual-interim-reports. 

If you wish to submit a proxy vote for this meeting, please submit your vote online at  www.signalshares.com . For your vote to be valid please ensure that it is received by no later than 12.00 NOON on 21 April 2022. Alternatively, should you wish to vote via the CREST system, please see the instructions in the Notice.  

For further information please contact:

Belluscura plc	www.belluscura.com
Robert Rauker, Chief Executive Officer	via Walbrook PR
Anthony Dyer, Chief Financial Officer
SPARK Advisory Partners Limited (NOMAD)	Tel: [phone]
Neil Baldwin
Dowgate Capital Limited (Broker)	Tel: [phone]
James Serjeant / Nicholas Chambers
Walbrook PR Ltd (Media & Investor Relations)	Tel: [phone] or [e-mail]
Paul McManus / Sam Allen	Mob: [phone]

About Belluscura plc ( www.belluscura.com )

Belluscura is a UK medical device company focused on developing oxygen enrichment technology spanning broad industries and therapies. Our innovative oxygen technologies are designed with a global purpose: to create improved health and economic outcomes for the patients, healthcare providers and insurance organisations.

 

 

END

 

 

MSCJBMATMTJJBLT